Boehringer VTU Extend Protein Production Pact

Boehringer Ingelheim and VTU Technology, a contract research and development company, have renewed their global technology collaboration under which VTU offers a broad technology platform for Pichia pastoris protein production and is responsible for carrying out the joint development program at its facilities. Boehringer has extended the ongoing technology agreement with VTU in an effort to further strengthen Pichia´s position as a highly attractive host for the production of biopharmaceuticals.

“The ongoing commitment of Boehringer Ingelheim in our technology collaboration underlines the skills and capabilities of our great team. We are very much looking forward to new exciting developments in this fruitful collaboration,” said Dr. Thomas Purkarthofer, head of business development at VTU Technology.

“We are excited about the continuation of our successful collaboration with VTU Technology. Together we established Pichia pastoris as innovative platform for the manufacture of biopharmaceuticals,” said Georg Klima, executive director Process Science Austria at Boehringer Ingelheim. “With the renewal of our collaboration we will further expand our technological lead for Boehringer Ingelheim’s own development projects as well as for Boehringer Ingelheim BioXcellence customers globally.”